This inventor holds 6 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1984-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Basel, CH (1984 - 1986)
- Basel, DE (1984 - 1987)
Company Filing History:
Years Active: 1984-1987
Title: Irmgard Boettcher: Innovator in Pharmaceutical Chemistry
Introduction
Irmgard Boettcher is a distinguished inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on diphosphonic acid derivatives and anti-inflammatory imidazole derivatives. With a total of 6 patents to her name, her research has had a notable impact on the development of new pharmaceutical preparations.
Latest Patents
Irmgard's latest patents include groundbreaking work on diphosphonic acid derivatives. These derivatives are characterized by the formula wherein X is cyano, 2-cyanoethyl, or 3-aminopropyl, and Y is H, or X and Y together represent dimethylaminomethylene. Additionally, she has developed anti-inflammatory imidazole derivatives, which are defined by a specific formula where AR₁ and AR₂ each independently represent phenyl, optionally substituted by halogen atoms, alkyl groups, or alkoxy groups.
Career Highlights
Throughout her career, Irmgard has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. Her work has not only advanced the field of pharmaceutical chemistry but has also contributed to the development of effective treatments for various medical conditions.
Collaborations
Irmgard has collaborated with notable colleagues such as Clemens Rufer and Helmut Biere. These partnerships have fostered a collaborative environment that has enhanced the quality and scope of her research.
Conclusion
Irmgard Boettcher's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her as a key figure in the field. Her work continues to influence the development of new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile